应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01358 普华和顺
交易中 03-24 11:07:50
1.010
+0.000
0.00%
最高
1.010
最低
1.010
成交量
15.10万
今开
1.010
昨收
1.010
日振幅
0.00%
总市值
14.89亿
流通市值
14.89亿
总股本
14.74亿
成交额
15.25万
换手率
0.01%
流通股本
14.74亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
普华和顺(01358):主动终止四川睿健医疗于北京证券交易所其后上市
智通财经 · 03-12
普华和顺(01358):主动终止四川睿健医疗于北京证券交易所其后上市
普华和顺盘中异动 股价大涨5.61%报1.130港元
市场透视 · 03-12
普华和顺盘中异动 股价大涨5.61%报1.130港元
港股异动丨发盈警,普华和顺一度大跌超23%
中金财经 · 03-10
港股异动丨发盈警,普华和顺一度大跌超23%
两连降!输液器板块销售下滑,普华和顺2025年净利最高预降45%
深圳商报·读创 · 03-10
两连降!输液器板块销售下滑,普华和顺2025年净利最高预降45%
普华和顺(01358)2025年度财报:经调整净利润1.20亿元至1.47亿元
公告速递 · 03-09
普华和顺(01358)2025年度财报:经调整净利润1.20亿元至1.47亿元
普华和顺(01358)发盈警 预期2025年股东应占溢利8300万元至1.02亿元
智通财经 · 03-09
普华和顺(01358)发盈警 预期2025年股东应占溢利8300万元至1.02亿元
普华和顺(01358)2月股份变动月报表,股本维持不变
公告速递 · 03-04
普华和顺(01358)2月股份变动月报表,股本维持不变
普华和顺03月03日遭主力抛售35.7万元
市场透视 · 03-03
普华和顺03月03日遭主力抛售35.7万元
普华和顺02月25日主力净流出34.5万元 散户资金买入
市场透视 · 02-25
普华和顺02月25日主力净流出34.5万元 散户资金买入
普华和顺(01358)2月24日斥资114.97万港元回购82.3万股
智通财经 · 02-24
普华和顺(01358)2月24日斥资114.97万港元回购82.3万股
普华和顺(01358)更新翌日披露报表,回购17.6万股股份
公告速递 · 02-23
普华和顺(01358)更新翌日披露报表,回购17.6万股股份
普华和顺(01358)2月23日斥资24.26万港元回购17.6万股
智通财经 · 02-23
普华和顺(01358)2月23日斥资24.26万港元回购17.6万股
普华和顺(01358)更新翌日披露报表,回购53,000股股份,总额71,380港元
公告速递 · 02-20
普华和顺(01358)更新翌日披露报表,回购53,000股股份,总额71,380港元
普华和顺(01358)2月20日斥资7.14万港元回购5.3万股
智通财经 · 02-20
普华和顺(01358)2月20日斥资7.14万港元回购5.3万股
普华和顺(01358)更新翌日披露报表,回购768,000股股份
公告速递 · 02-13
普华和顺(01358)更新翌日披露报表,回购768,000股股份
普华和顺(01358)2月13日耗资102.174万港元回购76.8万股
智通财经 · 02-13
普华和顺(01358)2月13日耗资102.174万港元回购76.8万股
普华和顺(01358):四川睿健医疗2025年归母净利润约1.51亿元 同比增长17.99%
智通财经 · 02-12
普华和顺(01358):四川睿健医疗2025年归母净利润约1.51亿元 同比增长17.99%
普华和顺集团(01358)回购41万股股份,总额约54万港元
公告速递 · 02-06
普华和顺集团(01358)回购41万股股份,总额约54万港元
普华和顺(01358)2月5日斥资70.53万港元回购54.3万股
智通财经 · 02-05
普华和顺(01358)2月5日斥资70.53万港元回购54.3万股
普华和顺(01358)1月股份变动月报表,已发行总数保持不变
公告速递 · 02-04
普华和顺(01358)1月股份变动月报表,已发行总数保持不变
加载更多
公司概况
公司名称:
普华和顺
所属市场:
SEHK
上市日期:
--
主营业务:
普华和顺集团公司是一家主要从事医疗器械的研发及销售业务的公司。该公司通过三个部门开展业务。输液器业务分部主要从事研发、制造及销售高端输液器、静脉留置针产品、胰岛素针等业务。血液净化业务分部主要从事研发、制造及销售血液透析及血液净化医疗器械业务。再生医用生物材料业务分部主要从事研发及制造动物源性组织再生医用生物材料及人体组织修复替代产品业务。该公司主要在中国国内市场开展业务。
发行价格:
--
{"stockData":{"symbol":"01358","market":"HK","secType":"STK","nameCN":"普华和顺","latestPrice":1.01,"timestamp":1774320117001,"preClose":1.01,"halted":0,"volume":151000,"delay":0,"changeRate":0,"floatShares":1474000000,"shares":1474000000,"eps":0.11101560788154186,"marketStatus":"交易中","change":0,"latestTime":"03-24 11:07:50","open":1.01,"high":1.01,"low":1.01,"amount":152510,"amplitude":0,"askPrice":1.03,"askSize":9000,"bidPrice":1.01,"bidSize":49000,"shortable":0,"etf":0,"ttmEps":0.11069968671262928,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1774324800000},"marketStatusCode":2,"adr":0,"listingDate":1383840000000,"exchange":"SEHK","adjPreClose":1.01,"dividendRate":0.09703,"openAndCloseTimeList":[[1774315800000,1774324800000],[1774328400000,1774339200000]],"volumeRatio":0.708569,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01358","defaultTab":"news","newsList":[{"id":"2618132130","title":"普华和顺(01358):主动终止四川睿健医疗于北京证券交易所其后上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2618132130","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618132130?lang=zh_cn&edition=full","pubTime":"2026-03-12 21:04","pubTimestamp":1773320677,"startTime":"0","endTime":"0","summary":"智通财经APP讯,普华和顺(01358)发布公告,于2026年3月11日,基于对自身业务发展方向及对当前市场环境等关键因素的审慎分析,经认真研究和充分论证且与保荐机构深入沟通后,四川睿健医疗决定调整资本市场战略规划,并拟主动终止其后上市申请。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1413290.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01358","159891","BK1100"],"gpt_icon":0},{"id":"2618130213","title":"普华和顺盘中异动 股价大涨5.61%报1.130港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618130213","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618130213?lang=zh_cn&edition=full","pubTime":"2026-03-12 09:52","pubTimestamp":1773280355,"startTime":"0","endTime":"0","summary":"2026年03月12日早盘09时52分,普华和顺股票出现波动,股价大幅上涨5.61%。截至发稿,该股报1.130港元/股,成交量74.5万股,换手率0.05%,振幅4.67%。资金方面,该股资金流入79.061万港元,流出3.31万港元。普华和顺股票所在的医疗设备及用品行业中,整体涨幅为0.08%。其相关个股中,普华和顺、康沣生物-B、现代牙科涨幅较大,振幅较大的相关个股有健世科技-B、瑛泰医疗、普华和顺,振幅分别为6.47%、4.04%、3.74%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031209523595498660&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031209523595498660&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01358","BK1100"],"gpt_icon":0},{"id":"2618077096","title":"港股异动丨发盈警,普华和顺一度大跌超23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618077096","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618077096?lang=zh_cn&edition=full","pubTime":"2026-03-10 11:27","pubTimestamp":1773113221,"startTime":"0","endTime":"0","summary":"普华和顺(1358.HK)盘初大跌超23%至0.97港元,截至目前成交额仅688万港元。消息面上,公司发盈警,预计截至2025年底止年度,公司拥有人应占溢利8300万至1.02亿元,同比下跌32%至45%,主要由于输液器业务板块因集采几近全面施行而销售下降的影响。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202603/10/20260310590899.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202603/10/20260310590899.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260310/32056550.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK4588","VXUS","BK4585","01358","BK1100"],"gpt_icon":0},{"id":"2618020516","title":"两连降!输液器板块销售下滑,普华和顺2025年净利最高预降45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618020516","media":"深圳商报·读创","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618020516?lang=zh_cn&edition=full","pubTime":"2026-03-10 10:43","pubTimestamp":1773110617,"startTime":"0","endTime":"0","summary":"两连降!输液器板块销售下滑,普华和顺2025年净利最高预降45%","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603103667231270.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1100","01358"],"gpt_icon":0},{"id":"1152627007","title":"普华和顺(01358)2025年度财报:经调整净利润1.20亿元至1.47亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1152627007","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152627007?lang=zh_cn&edition=full","pubTime":"2026-03-09 19:52","pubTimestamp":1773057137,"startTime":"0","endTime":"0","summary":"本年度信息\n根据公告,普华和顺集团预计截至2025年12月31日止年度的经调整净利润介乎1.20亿元至1.47亿元,相比2024年约1.925亿元同比下降38%至24%。其中,公司拥有人应占净利润预计为0.83亿元至1.02亿元,相比2024年约1.508亿元同比下降45%至32%。\n业务分项\n公告显示,上述利润下滑主要由输液器业务板块销售下降所致,原因在于相关集采政策几近全面施行,对业务造成明显影响。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01358"],"gpt_icon":0},{"id":"2618215623","title":"普华和顺(01358)发盈警 预期2025年股东应占溢利8300万元至1.02亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618215623","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618215623?lang=zh_cn&edition=full","pubTime":"2026-03-09 19:51","pubTimestamp":1773057067,"startTime":"0","endTime":"0","summary":"智通财经APP讯,普华和顺(01358)发布公告,预计本集团将于截至2025年12月31日止年度取得纯利介乎人民币1.2亿元至人民币1.47亿元,相比截至2024年12月31日止年度约人民币1.93亿元减少38%至24%;及于截至2025年12月31日止年度取得本公司拥有人应占溢利介乎人民币8300万元至人民币1.02亿元,相比截至2024年12月31日止年度约人民币1.51亿元减少45%至32%。上述减少主要由于输液器业务板块因集采几近全面施行而销售下降的影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1411779.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01358","BK1100"],"gpt_icon":0},{"id":"1169044252","title":"普华和顺(01358)2月股份变动月报表,股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1169044252","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169044252?lang=zh_cn&edition=full","pubTime":"2026-03-04 16:56","pubTimestamp":1772614587,"startTime":"0","endTime":"0","summary":"普华和顺于2026年3月4日披露,截至2026年2月28日的股份变动月报表。报告期内,公司法定股本维持在5,000,000,000股,股份面值每股USD 0.0001,法定股本总额USD 500,000。本月底已发行普通股股数为1,473,589,098股,与上月底持平,公司无新增发行或库存股变动。报告显示,公司拟于2026年6月10日购回6,342,000股普通股,惟该等股份截至2月末尚未注销。普华和顺确认遵守香港联合交易所有限公司的相关上市规则及法律法规。公告由董事张月娥签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01358"],"gpt_icon":0},{"id":"2616376690","title":"普华和顺03月03日遭主力抛售35.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616376690","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616376690?lang=zh_cn&edition=full","pubTime":"2026-03-03 16:15","pubTimestamp":1772525756,"startTime":"0","endTime":"0","summary":"03月03日,普华和顺股价收平报1.29元,成交金额99.9万元,换手率0.05%,振幅2.33%,量比0.82。普华和顺今日主力资金净流出35.7万元,上一交易日主力净流出26.4万元。该股近5个交易日下跌6.52%,主力资金累计净流出123.3万元;近20日主力资金累计净流出30.8万元,其中净流出天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303162052a69c9b87&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303162052a69c9b87&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1100","01358"],"gpt_icon":0},{"id":"2614539710","title":"普华和顺02月25日主力净流出34.5万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2614539710","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614539710?lang=zh_cn&edition=full","pubTime":"2026-02-25 16:15","pubTimestamp":1772007318,"startTime":"0","endTime":"0","summary":"02月25日,普华和顺股价收平报1.38元,成交金额137.4万元,换手率0.07%,振幅2.17%,量比1.53。普华和顺今日主力资金净流出34.5万元,上一交易日主力净流出0万元。该股近5个交易日上涨2.99%,主力资金累计净流出34.5万元;近20日主力资金累计净流入58.1万元,其中净流入天数为2日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225161609a71d461f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225161609a71d461f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1100","01358"],"gpt_icon":0},{"id":"2613786713","title":"普华和顺(01358)2月24日斥资114.97万港元回购82.3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2613786713","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613786713?lang=zh_cn&edition=full","pubTime":"2026-02-24 19:51","pubTimestamp":1771933919,"startTime":"0","endTime":"0","summary":"智通财经APP讯,普华和顺(01358)发布公告,于2026年2月24日斥资114.97万港元回购82.3万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1406818.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","01358"],"gpt_icon":0},{"id":"1194321037","title":"普华和顺(01358)更新翌日披露报表,回购17.6万股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1194321037","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194321037?lang=zh_cn&edition=full","pubTime":"2026-02-23 18:10","pubTimestamp":1771841446,"startTime":"0","endTime":"0","summary":"普华和顺集团公司于2026年2月23日向香港联交所提交翌日披露报表。公告显示,公司在2026年2月23日回购176,000股普通股股份,约占回购前已发行股本的0.0119%,每股回购价格介乎1.37港元至1.38港元,总额约242,580港元。根据公告,此次回购完成后,公司已发行股本仍为1,473,589,098股,库藏股数为0。公司此前于2025年6月10日通过购回授权,目前剩余可回购股份数量为148,673,509股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01358"],"gpt_icon":0},{"id":"2613783718","title":"普华和顺(01358)2月23日斥资24.26万港元回购17.6万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2613783718","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613783718?lang=zh_cn&edition=full","pubTime":"2026-02-23 18:09","pubTimestamp":1771841397,"startTime":"0","endTime":"0","summary":"智通财经APP讯,普华和顺(01358)发布公告,于2026年2月23日该公司斥资24.26万港元回购17.6万股,回购价格为每股1.37-1.38港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a39576c19275d7a112dfc5c561201577","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1406353.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","01358"],"gpt_icon":0},{"id":"1133685679","title":"普华和顺(01358)更新翌日披露报表,回购53,000股股份,总额71,380港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1133685679","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133685679?lang=zh_cn&edition=full","pubTime":"2026-02-20 18:09","pubTimestamp":1771582183,"startTime":"0","endTime":"0","summary":"普华和顺集团公司于2026年2月20日更新翌日披露报表。公告显示,公司于当日回购股份53,000股,占当日前已发行股本约0.0036%。本次回购最高价为每股1.35港元,最低价为每股1.34港元,合计支付金额71,380港元。本次回购后,公司已发行股本仍为1,473,589,098股,暂无库存股。根据公告,公司于2025年6月10日获得购回授权,可购回最多148,673,509股。公司同时确认,已遵守香港联合交易所有限公司证券上市规则及相关法律法规的要求。公告由公司董事张月娥签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01358"],"gpt_icon":0},{"id":"2612026300","title":"普华和顺(01358)2月20日斥资7.14万港元回购5.3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2612026300","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612026300?lang=zh_cn&edition=full","pubTime":"2026-02-20 18:06","pubTimestamp":1771581986,"startTime":"0","endTime":"0","summary":"智通财经APP讯,普华和顺(01358)发布公告,于2026年2月20日斥资7.14万港元回购5.3万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1406079.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","01358"],"gpt_icon":0},{"id":"1197909406","title":"普华和顺(01358)更新翌日披露报表,回购768,000股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1197909406","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197909406?lang=zh_cn&edition=full","pubTime":"2026-02-13 18:41","pubTimestamp":1770979312,"startTime":"0","endTime":"0","summary":"普华和顺集团公司于2026年2月13日向香港联交所提交翌日披露报表,披露最新股份回购情况。根据公告,公司于2026年2月13日回购768,000股普通股,占回购前已发行股本约0.0521%,每股价格介乎港币1.32元至1.34元,总金额约为港币1,021,740元。公告显示,公司在回购完成后,已发行股本维持在1,473,589,098股,库藏股数量暂未变化。截至目前,公司合计回购股份18,436,000股,占购回授权决议通过当日已发行股本约1.24%。公司确认上述回购已遵守香港联交所证券上市规则及相关法律法规。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01358"],"gpt_icon":0},{"id":"2611153925","title":"普华和顺(01358)2月13日耗资102.174万港元回购76.8万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2611153925","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611153925?lang=zh_cn&edition=full","pubTime":"2026-02-13 18:36","pubTimestamp":1770978991,"startTime":"0","endTime":"0","summary":"智通财经APP讯,普华和顺(01358)公布,2026年2月13日耗资102.174万港元回购76.8万股股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1405285.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01358","BK1100"],"gpt_icon":0},{"id":"2610967944","title":"普华和顺(01358):四川睿健医疗2025年归母净利润约1.51亿元 同比增长17.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610967944","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610967944?lang=zh_cn&edition=full","pubTime":"2026-02-12 18:29","pubTimestamp":1770892177,"startTime":"0","endTime":"0","summary":"智通财经APP讯,普华和顺(01358)发布附属四川睿健医疗科技股份有限公司(四川睿健医疗)2025年业绩,收入约6.15亿元,同比增长27.22%;归属于四川睿健医疗股东的净利润约1.51亿元,同比增长17.99%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1404756.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01358","159891"],"gpt_icon":0},{"id":"1134051665","title":"普华和顺集团(01358)回购41万股股份,总额约54万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1134051665","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134051665?lang=zh_cn&edition=full","pubTime":"2026-02-06 18:31","pubTimestamp":1770373914,"startTime":"0","endTime":"0","summary":"普华和顺集团公司于2026年2月6日发布翌日披露报表,披露当日通过联交所回购普通股合计410,000股,占公司已发行股本约0.0278%。上述股份尚未注销,公司已发行股本仍约为1,473,589,098股,暂无库藏股结存。本次回购授权于2025年6月10日获股东大会批准,授权可回购股份总数为148,673,509股。公司将于2026年3月8日前暂缓进行任何新股发行或出售、转让库藏股的计划。公司确认,本次回购行为已获董事会正式授权,并遵循上市规则及相关法律规定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01358"],"gpt_icon":0},{"id":"2609376229","title":"普华和顺(01358)2月5日斥资70.53万港元回购54.3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2609376229","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609376229?lang=zh_cn&edition=full","pubTime":"2026-02-05 19:02","pubTimestamp":1770289328,"startTime":"0","endTime":"0","summary":"智通财经APP讯,普华和顺(01358)发布公告,于2026年2月5日该公司斥资70.53万港元回购54.3万股,回购价格为每股1.29-1.30港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402180.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"普华和顺(01358)2月5日斥资70.53万港元回购54.3万股","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","01358"],"gpt_icon":0},{"id":"1135676232","title":"普华和顺(01358)1月股份变动月报表,已发行总数保持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1135676232","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135676232?lang=zh_cn&edition=full","pubTime":"2026-02-04 16:41","pubTimestamp":1770194493,"startTime":"0","endTime":"0","summary":"普华和顺集团公司于2026年2月4日披露截至2026年1月31日的股份变动月报表。报告显示,公司本月已发行股份数及注册股本均无变化,股本结构保持稳定。期内并无任何新增发行或注销活动,公司已发行股份总数维持在1,473,589,098股。截至2026年1月月底,该购回事宜未对已发行股份总数产生实际影响。公司确认目前已符合香港联交所上市规定所要求的最低公众持股量比例。本次月报由公司董事张月娥签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01358"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.pwmedtech.com","stockEarnings":[{"period":"1week","weight":-0.0734},{"period":"1month","weight":-0.2463},{"period":"3month","weight":-0.2231},{"period":"6month","weight":-0.3416},{"period":"1year","weight":0.0954},{"period":"ytd","weight":-0.2171}],"compareEarnings":[{"period":"1week","weight":-0.0562},{"period":"1month","weight":-0.0769},{"period":"3month","weight":-0.054},{"period":"6month","weight":-0.0806},{"period":"1year","weight":0.0292},{"period":"ytd","weight":-0.0487}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"普华和顺集团公司是一家主要从事医疗器械的研发及销售业务的公司。该公司通过三个部门开展业务。输液器业务分部主要从事研发、制造及销售高端输液器、静脉留置针产品、胰岛素针等业务。血液净化业务分部主要从事研发、制造及销售血液透析及血液净化医疗器械业务。再生医用生物材料业务分部主要从事研发及制造动物源性组织再生医用生物材料及人体组织修复替代产品业务。该公司主要在中国国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.307692,"avgChangeRate":-0.032002},{"month":2,"riseRate":0.538462,"avgChangeRate":-0.007006},{"month":3,"riseRate":0.384615,"avgChangeRate":-0.016422},{"month":4,"riseRate":0.583333,"avgChangeRate":0.055185},{"month":5,"riseRate":0.666667,"avgChangeRate":0.043825},{"month":6,"riseRate":0.5,"avgChangeRate":0.044656},{"month":7,"riseRate":0.666667,"avgChangeRate":0.047586},{"month":8,"riseRate":0.5,"avgChangeRate":-0.026291},{"month":9,"riseRate":0.75,"avgChangeRate":0.030953},{"month":10,"riseRate":0.5,"avgChangeRate":0.015313},{"month":11,"riseRate":0.416667,"avgChangeRate":-0.037725},{"month":12,"riseRate":0.307692,"avgChangeRate":0.203131}],"exchange":"SEHK","name":"普华和顺","nameEN":"PW MEDTECH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.37.0","shortVersion":"4.37.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"普华和顺(01358)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供普华和顺(01358)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"普华和顺,01358,普华和顺股票,普华和顺股票老虎,普华和顺股票老虎国际,普华和顺行情,普华和顺股票行情,普华和顺股价,普华和顺股市,普华和顺股票价格,普华和顺股票交易,普华和顺股票购买,普华和顺股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"普华和顺(01358)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供普华和顺(01358)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}